What is the address of ELK MEDICAL?

The registered office of ELK MEDICAL is located at Rue Vinâve 171, 4030 Liège.

Is ELK MEDICAL still active?

Yes. According to the CBE (30 October 2026) ELK MEDICAL is active, legal situation “Normale toestand”, started on 6 October 2020.

Is ELK MEDICAL registered on Peppol?

Yes, ELK MEDICAL is registered on the Peppol network with ID 0208:0755767778.

What is the enterprise number of ELK MEDICAL?

The enterprise number of ELK MEDICAL is BE0755767778.

When was ELK MEDICAL founded?

ELK MEDICAL was founded on 6 October 2020.

Who are the directors of ELK MEDICAL?

According to the 2025 annual accounts, the directors of ELK MEDICAL are: Miriam EL KHOUMSI.

Is ELK MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 October 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ELK MEDICAL make in 2025?

ELK MEDICAL posted a profit after taxes of € 48,394 in financial year 2025.

What is the revenue of ELK MEDICAL?

As a small company, ELK MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 65,534.

ELK MEDICAL (Private Limited) - Liège - BE0755767778

Dossier ELK MEDICAL, printed on 30 October 2026 from databakkes.be/en/0755767778/elk-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ELK MEDICAL from Liège, company number BE0755767778, closed financial year 2025 with a result of € 48,394 after tax. For that financial year ELK MEDICAL recorded a gross margin of € 65,534 and equity of € 133,480. Compared with financial year 2024, the result moved from € 41,009 to € 48,394. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 21, 2026.

What it is worth Healthy

€ 133,480

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 48,394

▲ 18% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 122,373

▼ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 48,394 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 59

▼ 93% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 0

▼ € 32,673 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 70,574 Gross margin 2022: € 70,574 First fiscal year in the series	€ 132,693 Gross margin 2023: € 132,693 ▲ 88% vs 2022 (€ 70,574) Favourable step	€ 49,980 Gross margin 2024: € 49,980 ▼ 62% vs 2023 (€ 132,693) Unfavourable step	€ 65,534 Gross margin 2025: € 65,534 ▲ 31% vs 2024 (€ 49,980) Favourable step	▲ 31%
Profit after taxes	€ 50,341 Profit after taxes 2022: € 50,341 First fiscal year in the series	€ 102,876 Profit after taxes 2023: € 102,876 ▲ 104% vs 2022 (€ 50,341) Favourable step	€ 41,009 Profit after taxes 2024: € 41,009 ▼ 60% vs 2023 (€ 102,876) Unfavourable step	€ 48,394 Profit after taxes 2025: € 48,394 ▲ 18% vs 2024 (€ 41,009) Favourable step	▲ 18%
Equity	€ 151,854 Equity 2022: € 151,854 First fiscal year in the series	€ 133,480 Equity 2023: € 133,480 ▼ 12% vs 2022 (€ 151,854) Unfavourable step	€ 133,480 Equity 2024: € 133,480 Unchanged (€ 133,480) Unchanged	€ 133,480 Equity 2025: € 133,480 Unchanged (€ 133,480) Unchanged
Total debts	€ 7,457 Total debts 2022: € 7,457 First fiscal year in the series	€ 155,709 Total debts 2023: € 155,709 ▲ € 148,252 vs 2022 (€ 7,457) Unfavourable step	€ 74,475 Total debts 2024: € 74,475 ▼ 52% vs 2023 (€ 155,709) Favourable step	€ 48,453 Total debts 2025: € 48,453 ▼ 35% vs 2024 (€ 74,475) Favourable step	▼ 35%
Cash	€ 142,407 Cash 2022: € 142,407 First fiscal year in the series	€ 124,535 Cash 2023: € 124,535 ▼ 13% vs 2022 (€ 142,407) Unfavourable step	€ 134,742 Cash 2024: € 134,742 ▲ 8% vs 2023 (€ 124,535) Favourable step	€ 122,373 Cash 2025: € 122,373 ▼ 9% vs 2024 (€ 134,742) Unfavourable step	▼ 9%
Retained profit	€ 146,854 Retained profit 2022: € 146,854 First fiscal year in the series	€ 128,480 Retained profit 2023: € 128,480 ▼ 13% vs 2022 (€ 146,854) Unfavourable step	€ 128,480 Retained profit 2024: € 128,480 Unchanged (€ 128,480) Unchanged	€ 128,480 Retained profit 2025: € 128,480 Unchanged (€ 128,480) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 121,250 Dividend 2023: € 121,250 Unchanged (€ 0) Unchanged	€ 41,009 Dividend 2024: € 41,009 ▼ 66% vs 2023 (€ 121,250) Unchanged	€ 48,394 Dividend 2025: € 48,394 ▲ 18% vs 2024 (€ 41,009) Unchanged	▲ 18%
Balance sheet total	€ 159,311 Balance sheet total 2022: € 159,311 First fiscal year in the series	€ 289,189 Balance sheet total 2023: € 289,189 ▲ 82% vs 2022 (€ 159,311) Unchanged	€ 207,955 Balance sheet total 2024: € 207,955 ▼ 28% vs 2023 (€ 289,189) Unchanged	€ 181,933 Balance sheet total 2025: € 181,933 ▼ 13% vs 2024 (€ 207,955) Unchanged	▼ 13%

Key figures of ELK MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ELK MEDICAL?

What happened at ELK MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 21, 2026 New annual accounts for financial year 2025: profit of € 48,394 (▲ 18% vs 2024). filed late Source: NBB ↗
Oct 6, 2020 New establishment in Liège. KBO
Oct 6, 2020 Start of the company according to the CBE. KBO

In short

From € 50,341 profit in 2022 to € 48,394 profit in 2025.

Paid € 74,065 in corporate taxes since 2022.

Best year ever: 2023, with € 102,876 profit.

Paid out € 210,653 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Miriam EL KHOUMSI

ELK MEDICAL

Behind ELK MEDICAL is Miriam EL KHOUMSI.

Directors

According to the 2025 annual accounts

Miriam EL KHOUMSI

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Vinâve 171

4030 Liège

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Questiko

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0755.767.778
VAT number: BE 0755.767.778
Registered office: Rue Vinâve 171, 4030 Liège
Names & denominations: ELK MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 October 2020
Peppol: Active · Active since 19 Jun 2026

View on CBE Public ↗ Annual accounts (NBB) ↗